Article Information
History
- July 15, 2022.
Article Versions
- You are currently viewing Version 1 of this article (July 15, 2022 - 11:31).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alexander Viloria Winnett1,§,
- Reid Akana1,§,
- Natasha Shelby1,§,
- Hannah Davich1,
- Saharai Caldera1,
- Taikun Yamada2,3,
- John Raymond B. Reyna2,
- Anna E. Romano1,
- Alyssa M. Carter1,
- Mi Kyung Kim1,
- Matt Thomson1,
- Colten Tognazzini4,
- Matthew Feaster4,
- Ying-Ying Goh4,
- Yap Ching Chew2,3 and
- Rustem F. Ismagilov1,*
- 1California Institute of Technology, Pasadena, CA
- 2Pangea Laboratory LLC, Tustin, CA
- 3Zymo Research Corp., Irvine, CA
- 4Pasadena Public Health Department, Pasadena, CA
- ↵*Corresponding author: rustem.admin{at}caltech.edu
↵§ These authors contributed equally to this report
Posted July 15, 2022.
Extreme differences in SARS-CoV-2 Omicron viral loads among specimen types drives poor performance of nasal rapid antigen tests for detecting presumably pre-infectious and infectious individuals, predicting improved performance of combination specimen antigen tests
